With safety signal case volumes increasing 30 to 50 percent annually, how are pharmacovigilance teams managing with today’s constrained budgets, and what can real-world data and advanced cognitive computing do for tomorrow? This webinar will feature pharmacovigilance industry experts from across life sciences as they discuss:
- What trends and challenges are safety signal teams facing today and how are they currently managing these issues?
- With 70% of biopharma seeing a maturity gap in safety signal analytics processing, what feasible steps will be taken toward improving safety signal analytics this year?
- What can we really expect from Real-World Data, Real-World Evidence, and Advanced Cognitive Computing – and when?
- What does the FDA’s adoption of Real-World Data and Real-World Evidence mean for the life sciences industry?
Join the featured speakers as they bring together top pharmacovigilance industry professionals to engage in this invaluable conversation on the challenges, successes and future innovations relevant to safety signal analytics. Don’t miss this important discussion, register here now.
Elizabeth Smalley, Director of Product Management and Data and Analytics, ArisGlobal
With over 15 years of experience across data analytics, Elizabeth Smalley has a passion for exploring the intersection of data science and human reasoning, with experience bringing AI-powered software to market to drive safety and clinical outcomes for patients and clinicians. In her current role, she leads ArisGlobal’s teams managing Data Platform, LifeSphere Clarity and LifeSphere Signals, Risk Management product lines.
Anand Ananthakrishnan, Senior Director of Drug Safety and Pharmacovigilance, Blueprint Medicines, Cambridge, MA
With over 20+ years expertise in the pharmacovigilance industry, Anand Ananthakrishnan is currently the Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines – a Biotechnology firm in Cambridge, Massachusetts. Prior to Blueprint Medicines, he held positions as the Director of PV Safety Systems and Operations at Fresenius Medical Care North America and served as the Associate Director of Safety Systems at Vertex Pharmaceuticals. He is a strong proponent of use of technology in PV and has been a front runner in deploying state of the art systems for efficiency gain across all facets of the domain. He is a strong believer in an integrated ecosystem for information flow between case processing, signal detection, literature search and submissions systems. He was awarded the “All Star Award” for Innovation at the Breakthrough 2022 conference held in Boston last year.
Emmanuel “Manny” Belabe, Vice President Solution Consulting, Global Commercial Organization, ArisGlobal
Emmanuel Belabe, better known as “Manny”, has worked within ArisGlobal in a number of different roles over his 15 years with the company. During that time, he developed an approach that sought to educate clients on best practices for leveraging ArisGlobal products, while advocating on the best way to deliver additional value through the implementation of additional ArisGlobal solutions. This led to roles as Product Owner for Safety Solutions, and to his current role VP of Solution Consulting where he is responsible for implementing tightly integrated tools that fit within the company’s vision of providing a unified platform across all R&D domains
Dr. Ponnappa M P, Director, Product Management, ArisGlobal
Dr. Ponnappa is an experienced product leader with over 15 years of expertise in product management activities, and a focus on collaboration between customer, company and cross-functional partners to deliver successful results. His specialties include conducting market research, requirement gathering and analysis, product strategy and managing the product roadmap.
Who Should Attend?
Professionals from the Safety and Pharmacovigilance divisions of pharma, sponsors, CROs including but not limited to:
- Head of PV Operations
- Risk Physicians
- Head of Signaling
- Sr. Director of PV Operations
- PV Safety
- Drug Safety
- Qualified Person for Pharmacovigilance (QPPV)
What You Will Learn
Attendees will gain insights into:
- Industry trends and challenges in safety signal analytics
- How teams are solving for these problems today
- How real-world data and advanced cognitive computing are creating innovations now and in the future for safety signal analytics
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.